FasL ability to promote tumor growth was confirmed by a study showing that FasL stimulation on apoptosis-resistant tumor cells activates downstream signaling cascade involving urokinase plasminogen activator, which ultimately induces motility and invasiveness. The gene discussed is PLAU; the disease is neoplasm.